[
    {
        "SNP ID": "rs516243",
        "SNP Name": "CASZ1 A10750432G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs9424398",
        "SNP Name": "CNR2 T24221834G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/19442614",
        "Video": null,
        "Tags": "adenylate,adenylate cyclase,allergies,allergy,amphetamine,anti-inflammatory,arteries,artery,B-cells,blood pressure,bone,bone homeostasis,bones,brain,brain development,cannabinoid,Cannabinoid receptor 2,cannabinoid receptor activity,cannabinoid signaling pathway,CB-2,CB2,CB2A,CB2B,Cell membrane,Cell membrane; Multi-pass membrane protein,Cell projection,Cell projection \u203a dendrite,chemical sensitivity,CNR,CNR2,CVD,CX5,dendrite,dopamine,drug,drug response,drugs,endocannabinoid 2-arachidonoylglycerol,extrinsic component of cytoplasmic side of plasma membrane,G-protein coupled receptor,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glutamate,hCB2,heart,Heterotrimeric G protein-coupled receptor,high BP,histamine,immune response,immune system,inflammation,inflammatory,inflammatory response,integral component of plasma membrane,lipopolysaccharide,low BP,mast cell,mast cell activation syndrome,mast cells,MCAS,MCS,Membrane,multiple chemical sensitivity,negative regulation of action potential,negative regulation of inflammatory response,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,negative regulation of synaptic transmission,neurons,neurotransmitters,nitric oxide,NK cells,nociceptive transmission,norepinephrine,NOS,pain,pain tolerance,Perikaryon,plasma membrane,receptor,response to amphetamine,response to lipopolysaccharide,rs9424398,sensory perception of pain,serotonin,T24221834G,Transducer",
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs11688",
        "SNP Name": "JUN c.750G/A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs6665776",
        "SNP Name": "PTGER3 G90650T",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs3176860",
        "SNP Name": "VCAM1 A71159137G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs3176879",
        "SNP Name": "VCAM1 G71175745A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs1058184",
        "SNP Name": "KCNA3 T*232G",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Potassium Chloride"
    },
    {
        "SNP ID": "rs5275",
        "SNP Name": "PTGS2 A186649221G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 20"
    },
    {
        "SNP ID": "rs4950928",
        "SNP Name": "CHI3L1 C131G",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gentamicin Sulfate"
    },
    {
        "SNP ID": "rs1800896",
        "SNP Name": "IL10 T206946897C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Formaldehyde"
    },
    {
        "SNP ID": "rs16944",
        "SNP Name": "IL1B C-511T",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs2322659",
        "SNP Name": "LCT A1639S",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs2228014",
        "SNP Name": "CXCL12 I138I",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Insect Cell"
    },
    {
        "SNP ID": "rs1376877",
        "SNP Name": "ABI2 C204272090T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "A-Tocopheryl Hydrogen Succinate"
    },
    {
        "SNP ID": "rs10932201",
        "SNP Name": "CREB1 G208426257A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amphotericin B"
    },
    {
        "SNP ID": "rs2254137",
        "SNP Name": "CREB1 C208444028A",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amphotericin B"
    },
    {
        "SNP ID": "rs72551314",
        "SNP Name": "CYP27a1 G159null",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs72551322",
        "SNP Name": "CYP27a1 A479G",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs2767",
        "SNP Name": "CHRND A233400074G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Benzethonium Chloride"
    },
    {
        "SNP ID": "rs6742078",
        "SNP Name": "UGT1A1 G179250T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6742078",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin conjugation,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,cancer,cancerous,CANX,carcinogen,Cardiovascular,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,Cholelithiasis,Cholelithiasis Risk in Sickle Cell Anemia,cirrhosis,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,CVD,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Gallstones,Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heart,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver cirrhosis,liver development,Membrane,Microsome,mortality in sepsis,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,Prostate Cancer,protects from bladder cancer,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,serum bilirubin,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of compone",
        "Group": "Human Serum Albumin"
    },
    {
        "SNP ID": "rs6742078",
        "SNP Name": "UGT1A1 G179250T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6742078",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin conjugation,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,cancer,cancerous,CANX,carcinogen,Cardiovascular,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,Cholelithiasis,Cholelithiasis Risk in Sickle Cell Anemia,cirrhosis,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,CVD,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Gallstones,Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heart,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver cirrhosis,liver development,Membrane,Microsome,mortality in sepsis,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,Prostate Cancer,protects from bladder cancer,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,serum bilirubin,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of compone",
        "Group": "Ovalbumin"
    },
    {
        "SNP ID": "rs237875",
        "SNP Name": "CTSL1 A8782406G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Benzethonium Chloride"
    },
    {
        "SNP ID": "rs901865",
        "SNP Name": "HRH1 T-17C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs901865",
        "Video": "sd6UujGt7b8",
        "Tags": "adrenal medulla,agonist-induced receptor downregulation,catecholamine,Cell membrane,cellular response to histamine,central nervous system,cognition,cytoplasmic loops,Disulfide bond,downregulation,drug reaction,drugs,eosinophil chemotaxis,G-protein coupled receptor,G-protein coupled receptor activity,G-protein coupled receptor signaling pathway,Glycoprotein,H1R,HH1R,histamine,Histamine H1 receptor,histamine induced schizophrenia,histamine receptor activity,histamine receptors,HRH1,immune system,inflammation,inflammatory response,inositol,inositol phosphate-mediated signaling,integral component of plasma membrane,learning,Lipoprotein,Membrane,memory,mental disorder,Multi-pass membrane protein,muscle,muscle tone,neurotransmission,neurotransmitters,Palmitate,phosphate,phospholipase C-activating G-protein coupled receptor signaling pathway,Phosphoprotein,Phosphorylation,plasma membrane,Polymorphism,positive regulation of inositol trisphosphate biosynthetic process,positive regulation of vasoconstriction,Receptor,Red man syndrome,regulation of synaptic plasticity,regulation of vascular permeability,schizophrenia,terminal venules,Transducer,Transmembrane,Transmembrane helix,vancomycin,visual learning",
        "Group": "Protamine Sulphate"
    },
    {
        "SNP ID": "rs346070",
        "SNP Name": "HRH1 T*1687C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs346070",
        "Video": "sd6UujGt7b8",
        "Tags": "adrenal medulla,agonist-induced receptor downregulation,antipsychotic medication,Antipsychotics,benzo,benzodiazepin,BMI,catecholamine,Cell membrane,cellular response to histamine,central nervous system,cognition,cytoplasmic loops,Disulfide bond,downregulation,drug metabolism,drug reaction,eosinophil chemotaxis,G-protein coupled receptor,G-protein coupled receptor activity,G-protein coupled receptor signaling pathway,GABA,Glycoprotein,H1R,HbA1c,HH1R,histamine,Histamine H1 receptor,histamine induced schizophrenia,histamine receptor activity,histamine receptors,HRH1,Hyperglycemia,immune system,inflammation,inflammatory response,inositol,inositol phosphate-mediated signaling,integral component of plasma membrane,learning,Lipoprotein,Membrane,memory,mental disorder,Multi-pass membrane protein,Muscarine,muscarinic acetylcholine receptor M3 (CHRM3),muscarinic M3 receptors,muscle,muscle tone,neurotransmission,neurotransmitters,Palmitate,Pharmacogenetics,phosphate,phospholipase C-activating G-protein coupled receptor signaling pathway,Phosphoprotein,Phosphorylation,plasma membrane,Polymorphism,positive regulation of inositol trisphosphate biosynthetic process,positive regulation of vasoconstriction,Receptor,regulation of synaptic plasticity,regulation of vascular permeability,schizophrenia,Schizophrenia research,SSRI,terminal venules,Transducer,Transmembrane,Transmembrane helix,visual learning,Weight gain",
        "Group": "Protamine Sulphate"
    },
    {
        "SNP ID": "rs3729931",
        "SNP Name": "RAF1 G12626516A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs72555366",
        "SNP Name": "GLB1 A178C",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs72555360",
        "SNP Name": "GLB1 A171C",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs72555392",
        "SNP Name": "GLB1 A59H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs72555358",
        "SNP Name": "GLB1 C145T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs1129055",
        "SNP Name": "CD86 A228T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs1799852",
        "SNP Name": "TF Leu247Leu",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Human Serum Albumin"
    },
    {
        "SNP ID": "rs1799852",
        "SNP Name": "TF Leu247Leu",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Ovalbumin"
    },
    {
        "SNP ID": "rs1049296",
        "SNP Name": "TF C34378T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": "AD,Alzheimer,Alzheimer's disease,anemia,anion,Antiretroviral,Antiretroviral Therapy,apical plasma membrane,ATRAF,Atransferrinemia,basal part of cell,basal plasma membrane,Beta-1 metal-binding globulin,bicarbonate,blood coagulation,blood microparticle,cell surface,cellular iron ion homeostasis,cerebrospinal fluid amyloid beta,Cerebrospinal Fluid Biomarkers,coagulation,coated pit,cytoplasmic membrane-bounded vesicle,degradation,dementia,diabetes,Disulfide bond,dopamine,early endosome,endocytic vesicle,endosome membrane,extracellular region,extracellular space,extracellular vesicular exosome,Fe,Fe3+,ferric iron binding,glioma,Glycoprotein,Haemochromatosis,heme,hemoglobin levels,Hereditary Haemochromatosis,HFE,hypochromic,hypochromic anemia,Ion transport,IQ,iron,iron dyshomeostasis,iron metabolism,iron overload,Iron transport,Iron uptake,late endosome,lead,Metal-binding,Methylation,microcytic,microcytic hypochromic anemia,mild cognitive impairment,neurodegenerative disease,Neuropathic Pain,oxidative stress,Parkinson,Parkinson's diseases,PD,perinuclear region of cytoplasm,platelet,platelet activation,platelet degranulation,recycling endosome,reticuloendothelial system,retina homeostasis,ROS,secretory granule lumen,Serotransferrin,serum ferritin,Siderophilin,TF,Transferrin,transferrin glycosylation,transferrin transport,transmembrane transport,Transport,tremor,TRFE,type 2 diabetes,vesicle",
        "Group": "Human Serum Albumin"
    },
    {
        "SNP ID": "rs1049296",
        "SNP Name": "TF C34378T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": "AD,Alzheimer,Alzheimer's disease,anemia,anion,Antiretroviral,Antiretroviral Therapy,apical plasma membrane,ATRAF,Atransferrinemia,basal part of cell,basal plasma membrane,Beta-1 metal-binding globulin,bicarbonate,blood coagulation,blood microparticle,cell surface,cellular iron ion homeostasis,cerebrospinal fluid amyloid beta,Cerebrospinal Fluid Biomarkers,coagulation,coated pit,cytoplasmic membrane-bounded vesicle,degradation,dementia,diabetes,Disulfide bond,dopamine,early endosome,endocytic vesicle,endosome membrane,extracellular region,extracellular space,extracellular vesicular exosome,Fe,Fe3+,ferric iron binding,glioma,Glycoprotein,Haemochromatosis,heme,hemoglobin levels,Hereditary Haemochromatosis,HFE,hypochromic,hypochromic anemia,Ion transport,IQ,iron,iron dyshomeostasis,iron metabolism,iron overload,Iron transport,Iron uptake,late endosome,lead,Metal-binding,Methylation,microcytic,microcytic hypochromic anemia,mild cognitive impairment,neurodegenerative disease,Neuropathic Pain,oxidative stress,Parkinson,Parkinson's diseases,PD,perinuclear region of cytoplasm,platelet,platelet activation,platelet degranulation,recycling endosome,reticuloendothelial system,retina homeostasis,ROS,secretory granule lumen,Serotransferrin,serum ferritin,Siderophilin,TF,Transferrin,transferrin glycosylation,transferrin transport,transmembrane transport,Transport,tremor,TRFE,type 2 diabetes,vesicle",
        "Group": "Ovalbumin"
    },
    {
        "SNP ID": "rs734312",
        "SNP Name": "WFS1 A611H",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs3816873",
        "SNP Name": "MTTP I28T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 20"
    },
    {
        "SNP ID": "rs4444903",
        "SNP Name": "EGF A110834110G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Taurodeoxycholate"
    },
    {
        "SNP ID": "rs4444903",
        "SNP Name": "EGF A110834110G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Urea"
    },
    {
        "SNP ID": "rs2237051",
        "SNP Name": "EGF M708I",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Urea"
    },
    {
        "SNP ID": "rs2069762",
        "SNP Name": "IL2 T4671G",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Formaldehyde"
    },
    {
        "SNP ID": "rs1449683",
        "SNP Name": "FGF2 S52S",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs1048201",
        "SNP Name": "FGF2/NUDT6 A209G",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs1490453",
        "SNP Name": "NR3C2 G149321346A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs6897932",
        "SNP Name": "IL7 T23148959C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs2243250",
        "SNP Name": "IL4 C-589",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs2243250",
        "SNP Name": "IL4 C-589",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs2243250",
        "SNP Name": "IL4 C-589",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs2070874",
        "SNP Name": "IL4 C-33T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs2070874",
        "SNP Name": "IL4 C-33T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs2070874",
        "SNP Name": "IL4 C-33T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs17286676",
        "SNP Name": "SLC4A9 G139749028A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Borate"
    },
    {
        "SNP ID": "rs258751",
        "SNP Name": "NR3C1 A593A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Acetone"
    },
    {
        "SNP ID": "rs258751",
        "SNP Name": "NR3C1 C3843271A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Acetone"
    },
    {
        "SNP ID": "rs322351",
        "SNP Name": "DUSP1 G*892A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs2067474",
        "SNP Name": "HRH2 G175109219A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Protamine Sulphate"
    },
    {
        "SNP ID": "rs1800689",
        "SNP Name": "HRH2 V181V",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Protamine Sulphate"
    },
    {
        "SNP ID": "rs1341239",
        "SNP Name": "PRL T3879G",
        "Risk Allele": "T",
        "Your Allele": "AC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Plasdone C"
    },
    {
        "SNP ID": "rs1265159",
        "SNP Name": "POU5F1 G31140047A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phenol Red"
    },
    {
        "SNP ID": "rs3025039",
        "SNP Name": "VEGFA C936T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs10434",
        "SNP Name": "VEGFA A*913G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs806368",
        "SNP Name": "CNR1 T88850100C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs806368",
        "Video": null,
        "Tags": "adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,aging,allergies,allergy,anandamide,anti-inflammatory,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,diabetes,dopamine,drug,drug binding,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,pregnancy,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs806368,sensory perception of pain,serotonin,smoking,spermatogenesis,T88850100C,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs11914",
        "SNP Name": "IFNGR1 S359S",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs3799488",
        "SNP Name": "IFNGR1 A25788G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs1327474",
        "SNP Name": "IFNGR1 -611G>A",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs2881766",
        "SNP Name": "ESR1 T152119119G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs8089",
        "SNP Name": "THBS2 A169617726C",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Calcium Chloride"
    },
    {
        "SNP ID": "rs730497",
        "SNP Name": "GCK G44223721A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs1799884",
        "SNP Name": "GCK G4955A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs10230120",
        "SNP Name": "COBL A577A",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Microcrystalline Cellulose"
    },
    {
        "SNP ID": "rs2293347",
        "SNP Name": "EGFR D994D",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 20"
    },
    {
        "SNP ID": "rs2293347",
        "SNP Name": "EGFR D994D",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs3812316",
        "SNP Name": "MLXIPL or MLX G24H",
        "Risk Allele": "C",
        "Your Allele": "GC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs6951030",
        "SNP Name": "STX1A T73133241G,",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs6942458",
        "SNP Name": "CACNA2D1 T295518C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Sulfate"
    },
    {
        "SNP ID": "rs929351",
        "SNP Name": "CACNA2D1 A220139C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Sulfate"
    },
    {
        "SNP ID": "rs10264272",
        "SNP Name": "CYP3A5*6 G624A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs10264272",
        "Video": null,
        "Tags": "Acids,ado-trastuzumab emtansine,Alfentanil,alkaloid catabolic process,Alprazolam,alternative splicing,Amiodarone,Amitriptyline,Amlodipine,AmprenavirApixaban,Aprepitant,Argatroban,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Astemizole,Atorvastatin,Axitinib,Azelastine,Beclomethasone,blood pressure,Boceprevir,BP,Brentuximab vedotin,Buprenorphine,Buspirone,Cabazitaxel,Caffeine,calcineurin inhibitors,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,Chloramphenicol,Chloroquine,Chlorphenamine,cholesterol,Cilostazol,Cimetidine,Ciprofloxacin,Cisapride,Clarithromycin,Clonidine,Clopidogrel,Cocaine,Codeine,COMPOUNDS,Crizotinib,CyclophosphamideCyclosporine,cyclosporine,cyclosporine levels,CYP,CYP P450,CYP3A5,CYPIIIA5,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A5,Cytochrome P450 HLp2,Cytochrome P450-PCN3,cytochromes,Dapsone,Dasatinib,Daunorubicin,Delavirdine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diltiazem,Disulfiram,Docetaxel,Dolutegravir,Domperidone,DRUG,drug catabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,electron,elevated blood pressure,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Eplerenone,Erlotinib,Erythromycin,Estradiol,ESTROGEN,Estrone,Ethosuximide,Etoposide,FAST METABOLIZER,fat,FATTY ACIDS,FelodipineFentanyl,Finasteride,Fluconazole,Fluoxetine,Flutamide,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Gefitinib,Gestodene,Granisetron,Halofantrine,Haloperidol,heme,heme binding,heme-thiolate monooxygenases,high BP,HORMONAL BALANCE,HORMONAL IMBALANCE,HORMONE,Hydrocortisone,hypertension,Ifosfamide,Iloperidone,Imatinib,Indinavir,intracellular membrane-bounded organelle,Irinotecan,iron,iron ion binding,Itraconazole,Ketoconazole,Lapatinib,Lercanidipine,Levomethadyl Acetate,Lidocaine,liver microsomes,Losartan,Lovastatin,Membrane,Metal-binding,Methadone,Microsome,Microsome membrane,microsomes,Midazolam,Mifepristone,Modafinil,Monooxygenase,monooxygenase activity,Mycophenolate mofetil,NADPH,NADPH-dependent electron transport pathway,Nateglinide,Nefazodone,Nelfinavir,Nevirapine,Nicardipine,Nifedipine,Nimodipine,Nisoldipine,Nitrendipine,Norethindrone,Norfloxacin,Nortriptyline,nucleotide,Ondansetron,Oxazepam,Oxcarbazepine,OXIDATION,oxidative demethylation,Oxidoreductase,oxidoreductase activity,Oxybutynin,Oxycodone,oxygen binding,P450,Paclitaxel,Paliperidone,Pentamidine,Perampanel,Peripheral membrane protein,pharmacogenomics,Phenelzine,Phenobarbital,Phenytoin,Pimozide,Ponatinib,Pravastatin,Praziquantel,Progesterone,Propranolol,protein,Quetiapine,Quinacrine,Quinine,Ranitidine,RAPID METABOLISM,RAPID METABOLIZER,Reserpine,RETINOID,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,Rifampicin,Rifapentine,Risperidone,Ritonavir,Rivaroxaban,Rosuvastatin,Salmeterol,Saquinavir,Saxagliptin,Sildenafil,Simvastatin,Sirolimus,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,STEROID,steroid metabolic process,Sulfasalazine,Sunitinib,synthesis,Tacrolimus,Tacrolimus dose selection,tacrolimus levels,Tamoxifen,Telithromycin,Temsirolimus,Teniposide,TESTOSTERONE,Thalidomide,TOXIC,TOXICITY,transcript,Trazodone,Tretinoin,Triazolam,Troleandomycin,TUMOR,TUMOR GROWTH,Udenafil,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Vardenafil,Verapamil,Vincristine,Voriconazole,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN,Zalcitabine,Zaleplon,Ziprasidone,Zolpidem",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs776746",
        "SNP Name": "CYP3A5*3 G237A",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs776746",
        "Video": null,
        "Tags": "acetaminophen,acetaminophen-induced acute liver failure,Acids,acute leukemia,acute rejection in kidney transplantation,adjuvant chemotherapy-induced neutropenia,ado-trastuzumab emtansine,advanced renal-cell carcinoma,AIDS,Alfentanil,alkaloid catabolic process,allogeneic hematopoietic stem cell transplantation,Alprazolam,alternative splicing,Amiodarone,Amitriptyline,Amlodipine,AmprenavirApixaban,anti-tuberculosis drug-induced hepatotoxicity,Aprepitant,Argatroban,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Astemizole,atherothrombotic,atherothrombotic events in stroke patients,Atorvastatin,Axitinib,Azelastine,Beclomethasone,blood pressure,Boceprevir,BP,breast cancer,Brentuximab vedotin,Buprenorphine,Buspirone,Cabazitaxel,Caffeine,calcineurin inhibitor nephrotoxicity,calcineurin inhibitors,calcineurin inhibitors in allogeneic hematopoietic SCT recipients,calcineurin-inhibitor,calcineurin-inhibitor toxicity in heart transplant,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,carcinoma,cerebral infarctions,chemotherapy,chemotherapy-induced neutropenia,Chloramphenicol,Chloroquine,Chlorphenamine,cholesterol,chronic myeloid leukemia,chronic obstructive pulmonary disease,Cilostazol,Cimetidine,Ciprofloxacin,Cisapride,Clarithromycin,Clonidine,Clopidogrel,Cocaine,Codeine,colorectal cancer,COMPOUNDS,COPD,Crizotinib,CyclophosphamideCyclosporine,cyclosporine,cyclosporine blood levels,cyclosporine metabolism,CYP,CYP P450,CYP3A5,CYPIIIA5,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A5,Cytochrome P450 HLp2,Cytochrome P450-PCN3,cytochromes,Dapsone,Dasatinib,Daunorubicin,Delavirdine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diltiazem,Disulfiram,Docetaxel,Dolutegravir,Domperidone,DRUG,drug catabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Early Age Acute Leukemia,electron,elevated blood pressure,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Eplerenone,Erlotinib,Erythromycin,Estradiol,ESTROGEN,Estrone,Ethosuximide,Etoposide,FAST METABOLIZER,fat,FATTY ACIDS,FelodipineFentanyl,Finasteride,Fluconazole,Fluoxetine,Flutamide,Fluticasone Propionate,Fluvastatin,Fluvoxamine,FOLFIRI chemotherapy,Gefitinib,Gestodene,Granisetron,Halofantrine,Haloperidol,heart transplant,heme,heme binding,heme-thiolate monooxygenases,hepatotoxicity,high BP,HIV,HIV-1,HORMONAL BALANCE,HORMONAL IMBALANCE,HORMONE,human proximal tubule cells,Hydrocortisone,hypertension,hypertension in pregnancy,Ifosfamide,Iloperidone,Imatinib,immunosuppressants,Indinavir,intracellular membrane-bounded organelle,Irinotecan,iron,iron ion binding,ischemic stroke,Itraconazole,Ketoconazole,kidney transplant,Lapatinib,Lercanidipine,leukemia,Levomethadyl Acetate,Lidocaine,lipid-lowering response to atorvastatin,lipids,liver failure,liver microsomes,liver transplant,Losartan,Lovastatin,lung,lung function,Membrane,Metal-binding,metastatic colorectal cancer,Methadone,Microsome,Microsome membrane,microsomes,Midazolam,Mifepristone,Modafinil,Monooxygenase,monooxygenase activity,Mycophenolate mofetil,NADPH,NADPH-dependent electron transport pathway,Nateglinide,Nefazodone,Nelfinavir,neutropenia,Nevirapine,Nicardipine,Nifedipine,Nimodipine,Nisoldipine,Nitrendipine,Norethindrone,Norfloxacin,Nortriptyline,nucleotide,Ondansetron,Oxazepam,Oxcarbazepine,OXIDATION,oxidative demethylation,Oxidoreductase,oxidoreductase activity,Oxybutynin,Oxycodone,oxygen binding,P450,Paclitaxel,paediatric tuberculosis,Paliperidone,Pentamidine,Perampanel,Peripheral membrane protein,Pharmacogenetics,pharmacogenomic,pharmacogenomics,pharmacokinetics,Phenelzine,Phenobarbital,Phenytoin,Pimozide,Ponatinib,Pravastatin,Praziquantel,Progesterone,Propranolol,prostate cancer,protein,proximal tubule cells,Quetiapine,Quinacrine,Quinine,Ranitidine,RAPID",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs1041988",
        "SNP Name": "CYP3A4 C1431T",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": "91ugq1mPu-k",
        "Tags": null,
        "Group": "FD&C Yellow #6 Aluminum Lake Dye"
    },
    {
        "SNP ID": "rs4646440",
        "SNP Name": "CYP3A4 C608T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs4646440",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs4646437",
        "SNP Name": "CYP3A4 C202T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs4646437",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,drug side effects,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,finasteride and prostate cancer,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs2246709",
        "SNP Name": "CYP3A4 T258C",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2246709",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,chemotherapy,Chenodeoxycholic acid,childhood acute lymphoblastic leukemia,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizi",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs55785340",
        "SNP Name": "CYP3A4*2 S222P",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://cancerres.aacrjournals.org/content/72/8_Supplement/1883.short",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs55901263",
        "SNP Name": "CYP3A4*5 P218R",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://cancerres.aacrjournals.org/content/72/8_Supplement/1883.short",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs12721627",
        "SNP Name": "CYP3A4*16 T185S",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807960/",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs55951658",
        "SNP Name": "CYP3A4*4 I118V",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://cancerres.aacrjournals.org/content/72/8_Supplement/1883.short",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs3091339",
        "SNP Name": "CYP3A4*_11460A>G(K96E) K96E",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs3091339",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs2740574",
        "SNP Name": "CYP3A4*1B A392G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2740574",
        "Video": "91ugq1mPu-k",
        "Tags": "1,8-cineole + NADP+ + H2O,8-cineole + NADPH + O2 = 2-exo-hydroxy-1,8-cineole 2-exo-monooxygenase,Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors,acting on paired donors with incorporation or reduction of molecular oxygen,Acute Leukemia,Adinazolam,ado-trastuzumab emtansine,AIDS Clinical Trials,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,Aliskiren,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,androgen metabolic process,antibiotic response,antibiotics,Antineoplastic Drugs,Antineoplastic Drugs metabolism,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benazepril,Benzphetamine,Benzyl alcohol,Bepridil,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,blood pressure,Boceprevir,Bortezomib,Bosentan,Bosutinib,breast and ovarian cancer,breast cancer,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,calcineurin inhibitors,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,cancer,cancerous,Carbamazepine,carbamazepine major metabolism,Carbinoxamine,carcinogen,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,chemotherapy,chemotherapy response,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpheniramine,Chlorpromazine,Chlorzoxazone,Cholecalciferol,cholesterol,chronic migraine,chronic myeloid leukemia patients receiving imatinib therapy,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,Clofibrate,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,colorectal cancer,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,cyclophosphamide metabolism pathway,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cyproterone,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desogestrel,Desvenlafaxine,detox,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,diabetes,Diabetes Mellitus,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Disopyramide,Disulfiram,DNA repair,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,Drospirenone,DRUG,drug catabolic process,drug metabolic process,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,E2,Early Age Acute Leukemia,Early Hypertensive Renal Disease,Econazole,Efavirenz,Eletriptan,elevated blood pressure,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,environmental,environmental factors,Enzalutamide,enzyme binding,epilepsy,Epinastine,Epi",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs7636",
        "SNP Name": "ACHE P477P",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs7636",
        "SNP Name": "ACHE P477P",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Chloride"
    },
    {
        "SNP ID": "rs2227692",
        "SNP Name": "SERPINE1 C38812087T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs2227692",
        "SNP Name": "SERPINE1 C38812087T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Chloride"
    },
    {
        "SNP ID": "rs7242",
        "SNP Name": "SERPINE1 T16067G",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs7242",
        "SNP Name": "SERPINE1 T16067G",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Chloride"
    },
    {
        "SNP ID": "rs121909011",
        "SNP Name": "CTFR R334W",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs113993959",
        "SNP Name": "CFTR G542X",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs121909005",
        "SNP Name": "CTFR G1647T",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs121908760",
        "SNP Name": "CFTR C2125T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs121908810",
        "SNP Name": "CTFR C2290T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs121908797",
        "SNP Name": "CTFR C2988G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs2167270",
        "SNP Name": "LEP G127881349A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs2020921",
        "SNP Name": "PLAT/COX2 A164T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs10974944",
        "SNP Name": "JAK2 C5070831G",
        "Risk Allele": "G",
        "Your Allele": "CG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Insect Cell"
    },
    {
        "SNP ID": "rs1051922",
        "SNP Name": "IFNB1 Y51Y",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Disodium Phosphate"
    },
    {
        "SNP ID": "rs12342831",
        "SNP Name": "B4GALT1 A47485G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs10813960",
        "SNP Name": "B4GALT1 C33170362T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs706118",
        "SNP Name": "BAG1 A13581C",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs1769259",
        "SNP Name": "FBP1 R218K",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "D-Fructose"
    },
    {
        "SNP ID": "rs1769259",
        "SNP Name": "FBP1 R218K",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Disodium Phosphate"
    },
    {
        "SNP ID": "rs1769259",
        "SNP Name": "FBP1 R218K",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs4129219",
        "SNP Name": "FBP1 T97390288C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4129219",
        "Video": null,
        "Tags": "6-bisphosphate,6-bisphosphate 1-phosphatase activity,active R-state,adiposity,allosteric inhibitor,AMP,AMP binding,appetite-stimulating neuropeptides,bound substrate,carbohydrate biosynthesis,carbohydrate metabolic process,carbohydrate metabolism,cellular response to drug,cellular response to magnesium ion,circulating satiety hormones,competitive inhibitor,complex allosteric regulation,D-fructose 1,D-fructose 6-phosphate,dephosphorylation,divalent cations,FBP1,feedback mechanism,fructose 1,Fructose 2,fructose 6-phosphate,fructose 6-phosphate metabolic process,fructose metabolic process,gluconeogenesis,glucose metabolic process,glycerol,hydrolase,identical protein binding,inactive T-state,insulin secretion,liver,Magnesium,metal ion binding,Metal-binding,modulate,monosaccharide binding,negative regulation of cell growth,negative regulation of glycolytic process,negative regulation of Ras protein signal transduction,nutrient excess,pancreatic beta-cells,pentose-phosphate pathway,phosphate,protein homotetramerization,protein in liver,recombinant enzyme,regulating glucose sensing,regulation of gluconeogenesis,regulator of appetite,rs4129219,schizophrenia,small molecule metabolic process,substrate,synergistic effects,T97390288C,weight gain",
        "Group": "Disodium Phosphate"
    },
    {
        "SNP ID": "rs4129219",
        "SNP Name": "FBP1 T97390288C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4129219",
        "Video": null,
        "Tags": "6-bisphosphate,6-bisphosphate 1-phosphatase activity,active R-state,adiposity,allosteric inhibitor,AMP,AMP binding,appetite-stimulating neuropeptides,bound substrate,carbohydrate biosynthesis,carbohydrate metabolic process,carbohydrate metabolism,cellular response to drug,cellular response to magnesium ion,circulating satiety hormones,competitive inhibitor,complex allosteric regulation,D-fructose 1,D-fructose 6-phosphate,dephosphorylation,divalent cations,FBP1,feedback mechanism,fructose 1,Fructose 2,fructose 6-phosphate,fructose 6-phosphate metabolic process,fructose metabolic process,gluconeogenesis,glucose metabolic process,glycerol,hydrolase,identical protein binding,inactive T-state,insulin secretion,liver,Magnesium,metal ion binding,Metal-binding,modulate,monosaccharide binding,negative regulation of cell growth,negative regulation of glycolytic process,negative regulation of Ras protein signal transduction,nutrient excess,pancreatic beta-cells,pentose-phosphate pathway,phosphate,protein homotetramerization,protein in liver,recombinant enzyme,regulating glucose sensing,regulation of gluconeogenesis,regulator of appetite,rs4129219,schizophrenia,small molecule metabolic process,substrate,synergistic effects,T97390288C,weight gain",
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs357564",
        "SNP Name": "PTCH1 P1164L",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs357564",
        "SNP Name": "PTCH1 P1164L",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Chloride"
    },
    {
        "SNP ID": "rs2236405",
        "SNP Name": "PTCH1 T1044S",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs2236405",
        "SNP Name": "PTCH1 T1044S",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Chloride"
    },
    {
        "SNP ID": "rs1800546",
        "SNP Name": "ALDOB A150P",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "D-Fructose"
    },
    {
        "SNP ID": "rs10306114",
        "SNP Name": "PTGS1/COX-1 A-287G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 20"
    },
    {
        "SNP ID": "rs10306114",
        "SNP Name": "PTGS1/COX-1 A-287G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs3842787",
        "SNP Name": "PTGS1/COX-1 P17L",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 20"
    },
    {
        "SNP ID": "rs3842787",
        "SNP Name": "PTGS1/COX-1 P17L",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs1800450",
        "SNP Name": "MBL2 G54A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "D-Mannose"
    },
    {
        "SNP ID": "rs2273697",
        "SNP Name": "ABCC2/MRP2 V417I",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phenol Red"
    },
    {
        "SNP ID": "rs17222723",
        "SNP Name": "ABCC2 V956G",
        "Risk Allele": "A",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phenol Red"
    },
    {
        "SNP ID": "rs2856111",
        "SNP Name": "MUC2 T1075747C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Taurodeoxycholate"
    },
    {
        "SNP ID": "rs10902088",
        "SNP Name": "MUC2 C1087972T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Taurodeoxycholate"
    },
    {
        "SNP ID": "rs2070762",
        "SNP Name": "TH T1090C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070762",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,autism,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,blood pressure,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,CFS,Chronic Fatigue Syndrome,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,diabetes,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,essential hypertension,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,Financial and Psychological Risk Attitudes,glycoside metabolic process,heart,heart development,heart morphogenesis,high BP,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,mental disorder,Metal-binding,migraine,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Schizophrenia,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,type I diabetes,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs28934580",
        "SNP Name": "TH G1010A//R337H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000013121/",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs28934581",
        "SNP Name": "TH A733C",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://omim.org/entry/191290",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs7483056",
        "SNP Name": "TH T7517C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7483056",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug induced liver injury,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,Flucloxacillin,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,liver injury,locomotory behavior,Mainly expressed in the brain and adrenal glands,Maternal Circulating Glucose Concentrations in Pregnancy,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,UC,Ulcerative Colitis and Flucloxacillin-induced liver injury,visual perception",
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs6356",
        "SNP Name": "TH V112M",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6356",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alcohol Dependence,alcohol metabolising genes,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,Bipolar Disorder,blood pressure,cardiovascular risk,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,diabetes,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,Dopaminergic pathway,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,high BP,hypertenstion,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,Maternal Circulating Glucose Concentrations in Pregnancy,mating behavior,melanosome membrane,memory,mental disorders,Metal-binding,migraine,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,Nicotine dependence,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,Parkinson's disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,personality traits,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,schizophrenia,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),suicidal behavior,synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,the protective role of a functional tyrosine hydroxylase polymorphism in nicotine dependence,TYH,Type 1 Diabetes,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs5215",
        "SNP Name": "KCNJ11 V250I",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs5219",
        "SNP Name": "KCNJ11 L23G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs4638289",
        "SNP Name": "SAA1 A18285774T",
        "Risk Allele": "A",
        "Your Allele": "AT",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Human Serum Albumin"
    },
    {
        "SNP ID": "rs7124442",
        "SNP Name": "BDNF C27677041T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amphotericin B"
    },
    {
        "SNP ID": "rs962369",
        "SNP Name": "BDNF A14186C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs8373",
        "SNP Name": "CNTF/ZFP91 S207G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs1800169",
        "SNP Name": "CNTF/ZFP91 1845-6G>A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs557564",
        "SNP Name": "TCN1 C59629305T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs526934",
        "SNP Name": "TCN1 G4939288A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs526934",
        "Video": null,
        "Tags": "B12,B12 binding,Belongs to the eukaryotic cobalamin transport proteins family,Binds vitamin B12 with femtomolar affinity and protects it from the acidic environment of the stomach,Cardioembolic Stroke,cardiovascular,cobalamin binding,cobalamin metabolic process,cobalamin transport,Cobalt,cobalt ion transport,Cobalt transport,Complete proteome,Congenital Heart Disease,Contains about 30% carbohydrates,cyanocobalamin,Disulfide bond,DLBCL,extracellular region,Follicular Lymphoma,Glycoprotein,Haptocorrin,HC,heart,heart disease,Ion transport,Large B-Cell Lymphoma,lower plasma B12 levels,Major constituent of secondary granules in neutrophils,MB12,methylcobalamin,non-Hodgkin lymphoma,plasma B12,Polymorphism,Produced by the salivary glands of the oral cavity in response to ingestion of food,prostate cancer,Protein R,reduced transport of transcobalamin,Reference proteome,Secreted,Signal,small molecule metabolic process,stroke,TC I,TC-1,TC1,TCI,TCN1,Transcobalamin,Transcobalamin I,Transcobalamin-1,Transport,vitamin B12,vitamin B12 binding,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs11231865",
        "SNP Name": "PYGM P410P",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs28940881",
        "SNP Name": "TYR A5083G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs1393350",
        "SNP Name": "TYR G105007A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs1946518",
        "SNP Name": "IL8 A4383C",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs1006737",
        "SNP Name": "CACNA1C G115699A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1006737",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,bipolar,bipolar disorder,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,cognitive vulnerability,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,depression,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insomnia,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,major depression,major depressive disorder,major psychoses,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,mental disorder,mental illness,metal ion binding,Metal-binding,mood disorder,neuronal cell body,Neuropsychiatry,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,psychiatric disease,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),schizophrenia,small molecule metabolic process,smooth muscle contraction involved in micturition,synapt",
        "Group": "Magnesium Sulfate"
    },
    {
        "SNP ID": "rs2159100",
        "SNP Name": "CACNA1C C271442T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2159100",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,bipolar,bipolar disorder,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,mental illness,metal ion binding,Metal-binding,neuronal cell body,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),small molecule metabolic process,smooth muscle contraction involved in micturition,synaptic transmission,The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity,The binding to the cytoplasmic N-terminal domain is calcium independent",
        "Group": "Magnesium Sulfate"
    },
    {
        "SNP ID": "rs216013",
        "SNP Name": "CACNA1C A2729632G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs216013",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),anticoagulant,ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,metal ion binding,Metal-binding,neuronal cell body,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),small molecule metabolic process,smooth muscle contraction involved in micturition,synaptic transmission,The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity,The binding to the cytoplasmic N-terminal domain is calcium independent but is essential for the ch",
        "Group": "Magnesium Sulfate"
    },
    {
        "SNP ID": "rs2302729",
        "SNP Name": "CACNA1C T709021C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2302729",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insomnia,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,metal ion binding,Metal-binding,neuronal cell body,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),small molecule metabolic process,smooth muscle contraction involved in micturition,synaptic transmission,The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity,The binding to the cytoplasmic N-terminal domain is calcium independent but is essential for the channel",
        "Group": "Magnesium Sulfate"
    },
    {
        "SNP ID": "rs28933382",
        "SNP Name": "KCNA1 P244H",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Potassium Chloride"
    },
    {
        "SNP ID": "rs731236",
        "SNP Name": "VDR TAQ",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs731236",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs731236,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,TAQ,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "D-Mannose"
    },
    {
        "SNP ID": "rs1544410",
        "SNP Name": "VDR VDR:BsmI",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1544410",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,25-Hydroxyvitamin D,Acute Kidney Injury,acute lymphoblastic leukemia,adiposity phenotypes,adolescent idiopathic scoliosis,age-related macular degeneration,Alternative splicing,asthma,autoantibodies,autoimmune,Autoimmune Disease Type 1 Diabetes,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,Bone Mineral Density,breast cancer,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cancer,cancer protection,cancerous,carcinogen,cardiovascular disease,cell morphogenesis,cellular calcium ion homeostasis,chronic obstructive pulmonary disease,chronic periodontitis,cirrhosis,colon adenoma,colorectal adenoma,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,congestive heart failure,Contains 1 nuclear receptor DNA-binding domain,COPD,Coronary Heart Disease,cutaneous melanoma,CVD,D3,decidualization,depression,diabetes,Disease mutation,DNA binding,DNA-binding,DNA-templated,drug reaction,drug response,endometrial cancer risk,estrogen,fatigue,femoral neck stress fractures,gene expression,genetic predisposition to disease,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,glioma,Head and Neck Squamous Cell Carcinoma,heart,heart disease,Hepatitis,Hepatitis C,hepatocellular carcinoma,Heterodimer with RXRA after vitamin D3 binding,high blood pressure,high BP,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypertension,hypocalcemia,immune regulator,immune response,immune system,immunization,immunogenetics,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,ischemic stroke,islet autoimmunity,lactation,leukemia,Leukocyte Telomere Length,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,liver,liver disease,longitudinal cognitive change,macular degeneration,mammary gland branching involved in pregnancy,Melanoma,metabolic pathway,Metal-binding,migraine,mineral metabolism,modulates soy intake and 25-hydroxyvitamin D supplementation benefits in cardiovascular disease,mortality,Most patients have total alopecia in addition to rickets,multiple sclerosis,Myopia,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,Nervous System Autoantibodies,non-Hodgkin lymphoma,Non-small Cell Lung Cancer,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Osteoporosis,Osteoporotic Fracture,Ovarian Cancer,Pancreas Cancer,pancreatic cancer,Parkinson,Parkinson's disease,PCOS,PD,pharmacogenomics,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,postmenopausal breast cancer,Primary Biliary Cirrhosis,prostate cancer,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,Renal Cancer,Response to Interferon/Ribavirin Therapy in Chroni",
        "Group": "D-Mannose"
    },
    {
        "SNP ID": "rs10506328",
        "SNP Name": "NFE2 A54687232C",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gentamicin Sulfate"
    },
    {
        "SNP ID": "rs10876550",
        "SNP Name": "NFE2 G16855614A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gentamicin Sulfate"
    },
    {
        "SNP ID": "rs6214",
        "SNP Name": "IGF1 G85810A",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs2238151",
        "SNP Name": "ALDH2 T12488C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2238151",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,oxidative stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Formaldehyde"
    },
    {
        "SNP ID": "rs968529",
        "SNP Name": "ALDH2 T35023C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs968529",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,gastric cancer,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Formaldehyde"
    },
    {
        "SNP ID": "rs671",
        "SNP Name": "ALDH2 G1369A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs671",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,Addictive Disorders,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,Alcohol-Induced Medical Diseases,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,Benign Prostate Hyperplasia,blood pressure,Breast and Prostate Cancer,breast cancer,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cardiovascular disease,cellular energy,Colorectal Cancer Risk,coronary artery disease,CVD,cytosolic,diabetes,diabetes mellitus,diabetic retinopathy,EC=1.2.1.3,electron,energy,esophageal cancer,esophageal squamous cell dysplasia,ethanol,ethanol degradation,ethanol oxidation,gastric adenocarcinoma,gastric cancer,Genetic and environmental factors,H2O,HDL cholesterol levels,high BP,Homotetramer,hypertension,intoxication,joint,Lipid Levels,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,Multiple Chemical Sensitivity,NAD,NADH,NADP,neurotransmitter,niacin,oesophageal squamous cell carcinoma,OSCC,Oxidoreductase,primary\r\nhepatocellular carcinoma,prostate cancer,SCC,scchn,smoking,Substance Dependence,Type 2 Diabetes,type 2 diabetes mellitus,xenobiotic",
        "Group": "Formaldehyde"
    },
    {
        "SNP ID": "rs671",
        "SNP Name": "ALDH2 G1369A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs671",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,Addictive Disorders,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,Alcohol-Induced Medical Diseases,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,Benign Prostate Hyperplasia,blood pressure,Breast and Prostate Cancer,breast cancer,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cardiovascular disease,cellular energy,Colorectal Cancer Risk,coronary artery disease,CVD,cytosolic,diabetes,diabetes mellitus,diabetic retinopathy,EC=1.2.1.3,electron,energy,esophageal cancer,esophageal squamous cell dysplasia,ethanol,ethanol degradation,ethanol oxidation,gastric adenocarcinoma,gastric cancer,Genetic and environmental factors,H2O,HDL cholesterol levels,high BP,Homotetramer,hypertension,intoxication,joint,Lipid Levels,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,Multiple Chemical Sensitivity,NAD,NADH,NADP,neurotransmitter,niacin,oesophageal squamous cell carcinoma,OSCC,Oxidoreductase,primary\r\nhepatocellular carcinoma,prostate cancer,SCC,scchn,smoking,Substance Dependence,Type 2 Diabetes,type 2 diabetes mellitus,xenobiotic",
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs16941667",
        "SNP Name": "ALDH2 C45068T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16941667",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,Gastric Cancer,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidative Stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Formaldehyde"
    },
    {
        "SNP ID": "rs861539",
        "SNP Name": "XRCC3 T241M",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs6494223",
        "SNP Name": "CHRFAM7A/CHRNA7 C78732T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Benzethonium Chloride"
    },
    {
        "SNP ID": "rs1909884",
        "SNP Name": "CHRFAM7A/CHRNA7 G121573A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Benzethonium Chloride"
    },
    {
        "SNP ID": "rs11636774",
        "SNP Name": "SORD A45317915C",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs8043226",
        "SNP Name": "SORD G45321593A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs1048943",
        "SNP Name": "CYP1A1*2C A4889G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1048943",
        "Video": "Uf_IW_Ahd6U",
        "Tags": "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),9-cis-retinoic acid biosynthetic process,acting on diphenols and related substances as donors,Acute Leukemia,advanced colorectal adenoma,Adverse Pregnancy Outcomes,aging,amine metabolic process,antibiotic response,antibiotics,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,atherosclerosis,basal cell carcinomas,BCCs,Benzphetamine,biliary tract cancers and stones,Bladder cancer,Bleomycin,breast cancer,camera-type eye development,cancer,cancerous,carcinogen,cardiovascular,cell proliferation,cellular lipid metabolic process,cellular response to organic cyclic compound,Cervical Cancer,childhood leukemia,Chlorzoxazone,cigarette smoking,clubfoot,colorectal cancer,colorectal neoplasia,community-acquired pneumonia,coumarin metabolic process,CVD,CYP P450,CYP1A1,Cytochrome P450 1A1,Cytochrome P450 form 6,Cytochrome P450-C,Cytochrome P450-P1,Dacarbazine,Dactinomycin,demethylase activity,detox,dibenzo-p-dioxin catabolic process,digestive tract development,drug metabolic process,drug metabolism,drug response,dysmenorrhea,E2,embryo development ending in birth or egg hatching,Endoplasmic reticulum membrane,environmental,environmental factors,epoxygenase P450 pathway,Esomeprazole,Esophageal Cancer,esophageal squamous cell carcinoma,estrogen,estrogen dominance,estrogen plus progestin hormone therapy,estrogen related cancer,Estrogen Synthesis,Estrone,fat metabolism,fatty acids,flavonoid 3'-monooxygenase activity,flavonoid metabolic process,Fluvastatin,Fluvoxamine,Gallbladder Cancer,Ginseng,GlcNAc,Glycosylation,Granisetron,Head and Neck Cancer,heart,heme binding,Heme group,heme-thiolate monooxygenase,hepatocyte differentiation,hormone therapy,hydrogen peroxide biosynthetic process,Idiopathic Male Infertility,insecticide metabolic process,iron (heme axial ligand),iron ion binding,Ketoconazole,leukemia,lipid metabolism,lipid related cardiovascular disease,liver,lung cancer,Malignant Brain Tumors,maternal process involved in parturition,Menadione,Metal binding,Microsome,Microsome membrane,mitochondrion,Monooxygenase,Myocardial Infarction,N-Acetylglucosamine,N-Acetyltransferase,NADPH,NADPH-dependent electron transport pathway,Non-Hodgkin lymphoma,omega-hydroxylase P450 pathway,oral cancer,ovarian cancer,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Papillary Thyroid Cancer,perimenopausal,Peripheral membrane protein,Pharmacogenomics,Picrotoxin,pneumonia,porphyrin-containing compound metabolic process,positive regulation of G1/S transition of mitotic cell cycle,postmenopausal breast cancer,pregnancy,Primaquine,Quinidine,Quinine,Renal Cell Cancer,response to antibiotic,response to arsenic-containing substance,response to drug,response to food,response to herbicide,response to hyperoxia,response to hypoxia,response to iron(III) ion,response to lipopolysaccharide,response to nematode,response to virus,response to vitamin A,response to wounding,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,sex hormones,Sex steroid metabolism,small molecule metabolic process,smoking,steroid hydroxylase activity,steroids,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Thiabendazole,uterine leiomyoma,vitamin A,vitamin D,vitamin D 24-hydroxylase activity,vitamin D metabolic process,xenobiotic,xenobiotic metabolic process",
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs1799814",
        "SNP Name": "CYP1A1*4 C2453A",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799814",
        "Video": "Uf_IW_Ahd6U",
        "Tags": "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),9-cis-retinoic acid biosynthetic process,acting on diphenols and related substances as donors,Advanced Colorectal Adenoma,aging,amine metabolic process,antibiotic response,antibiotics,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,atherosclerosis,Benzphetamine,Bladder cancer,Bleomycin,breast cancer,camera-type eye development,cancer,Cancer Susceptibility,cancerous,carcinogen,cell proliferation,cellular lipid metabolic process,cellular response to organic cyclic compound,Chlorzoxazone,colorectal cancer,colorectal neoplasia,coumarin metabolic process,CYP P450,CYP1A1,Cytochrome P450 1A1,Cytochrome P450 form 6,Cytochrome P450-C,Cytochrome P450-P1,Dacarbazine,Dactinomycin,demethylase activity,detox,dibenzo-p-dioxin catabolic process,digestive tract development,drug metabolic process,drug metabolism,drug response,E2,embryo development ending in birth or egg hatching,Endoplasmic reticulum membrane,environmental,environmental factors,epoxygenase P450 pathway,Esomeprazole,Esophageal Cancer,estrogen,estrogen dominance,estrogen related cancer,Estrogen Synthesis,Estrone,fat metabolism,fatty acids,flavonoid 3'-monooxygenase activity,flavonoid metabolic process,Fluvastatin,Fluvoxamine,Ginseng,GlcNAc,Glycosylation,Granisetron,heme binding,Heme group,heme-thiolate monooxygenase,hepatocyte differentiation,hydrogen peroxide biosynthetic process,insecticide metabolic process,iron (heme axial ligand),iron ion binding,Ketoconazole,lipid metabolism,liver,lung cancer,maternal process involved in parturition,Meat-Related Exposures,Menadione,Metal binding,Microsome,Microsome membrane,mitochondrion,Monooxygenase,N-Acetylglucosamine,NADPH,NADPH-dependent electron transport pathway,omega-hydroxylase P450 pathway,oral cancer,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,pancreatic cancer,Peripheral membrane protein,Picrotoxin,porphyrin-containing compound metabolic process,positive regulation of G1/S transition of mitotic cell cycle,Primaquine,Prostate Cancer,Quinidine,Quinine,response to antibiotic,response to arsenic-containing substance,response to drug,response to food,response to herbicide,response to hyperoxia,response to hypoxia,response to iron(III) ion,response to lipopolysaccharide,response to nematode,response to virus,response to vitamin A,response to wounding,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,sex hormones,small molecule metabolic process,steroid hydroxylase activity,steroids,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Thiabendazole,vitamin A,vitamin D,vitamin D 24-hydroxylase activity,vitamin D metabolic process,xenobiotic,xenobiotic metabolic process",
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs2069526",
        "SNP Name": "CYP1A2*1K -739T>G",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2069526",
        "Video": "JX91czj1oSg",
        "Tags": "2-hydroxylation,Acenocoumarol,acetaminophen,adverse reaction,aflatoxin B1,Agomelatine,Albendazole,Alitretinoin,alkaloid metabolic process,Almotriptan,Alosetron,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Anagrelide,Anastrozole,antidepressant,antidepressant metabolism,antidepressant response,antidepressant side effect,Antipyrine,Apixaban,Aprepitant,arachidonic acid metabolic process,aromatase activity,aromatic amine,ARTIFICIAL ESTROGEN,Asenapine,Atropine,Axitinib,Azelastine,Azithromycin,Benzyl alcohol,Betaxolol,Bortezomib,Bromazepam,Bromocriptine,Bupivacaine,Buprenorphine,Bupropion,caffeine,caffeine metabolism,caffeine oxidase activity,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,carcinogenic aromatic amine,Carmustine,Carvedilol,cellular respiration,cellular response to cadmium ion,Chlorpromazine,Chlorzoxazone,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clenbuterol,Clevidipine,Clobetasol propionate,Clomifene,Clomipramine,Clonidine,Clopidogrel,Clotrimazole,clozapine,compounds,Conjugated Estrogens,Cyclobenzaprine,CYP,CYP P450,CYP1A2,CYPIA2,CYTOCHROME,Cytochrome P(3)450,CYTOCHROME P450,Cytochrome P450 1A2,Cytochrome P450 4,Cytochrome P450-P3,Dacarbazine,Dapagliflozin,Dasatinib,Daunorubicin,Delavirdine,demethylase activity,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexfenfluramine,Dexmedetomidine,Diazepam,dibenzo-p-dioxin metabolic process,Diclofenac,Dinoprostone,Diphenhydramine,Domperidone,Dopamine,Doxepin,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Edetic Acid,Efavirenz,electron carrier activity,electron transport pathway,Eltrombopag,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enoxacin,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,ENZYME,enzyme binding,Epinephrine,epoxygenase P450 pathway,Ergotamine,Erlotinib,Erythromycin,escitalopram,escitalopram adverse reaction,Estradiol,ESTROGEN,Estrone,Estropipate,Ethanol,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Fluphenazine,Flutamide,Fluvastatin,Fluvoxamine,Frovatriptan,Gemfibrozil,Griseofulvin,Guanabenz,Haloperidol,HEME,heme binding,heme-thiolate monooxygenases,Hesperetin,heterocycle metabolic process,heterocyclic amines,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydrogen peroxide biosynthetic process,Iloperidone,Imatinib,imidazole,Imipramine,Imiquimod,inhaled insulin,Insulin Aspart,Insulin Detemir,Insulin Glargine,Insulin Glulisine,Insulin Lispro,Insulin Regular,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketoconazole,Lansoprazole,Leflunomide,Levobupivacaine,Levofloxacin,Lidocaine,LIVER,LIVER ENZYME,Lomefloxacin,Lopinavir,Lorcaserin,Losartan,Lumiracoxib,lung cancer,lung development,Malathion,Maprotiline,Meclizine,Melatonin,Membrane,Menadione,Metal-binding,Methadone,Methimazole,Methotrimeprazine,Methoxsalen,Methoxyflurane,methylation,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,molecular oxygen,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-hydroxylation,N3-demethylation,Nabumetone,NADPH,NADPH-dependent,Nafcillin,Naproxen,Nelfinavir,Nevirapine,Niclosamide,Nicotine,Nifedipine,Nilvadipine,Nisoldipine,Nitric Oxide,Nitroprusside,Norepinephrine,Norfloxacin,Nortriptyline,O-deethylation,Ofloxacin,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Oxaliplatin,oxidation,oxidation-reduction process,oxidative deethylation,oxidative demethylation,oxidizes,Oxidoreductase,oxidoreductase activity,Oxtriphylline,oxygen,P450,Palonosetron,Pantoprazole,Pazopanib,Peflox",
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs762551",
        "SNP Name": "CYP1A2*1F C164A",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs762551",
        "Video": "JX91czj1oSg",
        "Tags": "2-amino-1-methyl-6-phenylimidazo,2-amino-2,2-amino-3,2-amino-3-methylimidazo,2-amino-6-methyldipyrido,2-hydroxylation,4-dimethylimidazo,8-dimethylimidazo,Acenocoumarol,Acetaminophen,Aciclovir,adverse reaction due to clozapine,aflatoxin B1,Agomelatine,Albendazole,Alitretinoin,alkaloid metabolic process,Almotriptan,Alosetron,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Anagrelide,Anastrozole,Anti-coagulation Therapy,Anti-platelet,antibiotic response,antibiotics,Antipyrine,Apixaban,Aprepitant,arachidonic acid metabolic process,aromatase activity,aromatic amine,Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,arthritis,ARTIFICIAL ESTROGEN,Asenapine,Atropine,Axitinib,Azelastine,Azithromycin,Benzyl alcohol,Betaxolol,bioactivation of carcinogenic aromatic and heterocyclic amines,birth defect,bladder cancer,Bortezomib,breast cancer,Bromazepam,Bromocriptine,Bupivacaine,Buprenorphine,Bupropion,Caffeine,caffeine and risk of non-fatal myocardial infraction (MI),Caffeine metabolism,caffeine oxidase activity,caffeine pathway,cancer,cancerous,Carbamazepine,carcinogen,carcinogen-metabolizing enzymes,carcinogenic aromatic amine,cardio,cardiovascular,Carmustine,Carvedilol,Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin,catalyzation,catalyzing 2-hydroxylation,cellular respiration,cellular response to cadmium ion,Chlordiazepoxide,Chlorpromazine,Chlorzoxazone,chronic migraine,cigarette,cigarette smoking,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,cleft lip,cleft palate,Clenbuterol,Clevidipine,Clobetasol propionate,Clomifene,Clomipramine,Clonidine,Clopidogrel,Clotrimazole,Clozapine,coffee intake,colorectal adenoma,Colorectal Cancer,colorectal neoplasia,compounds,Conjugated Estrogens,CVD,Cyclobenzaprine,CYP,CYP P450,CYP1A2,CYPIA2,CYTOCHROME,Cytochrome P(3)450,CYTOCHROME P450,Cytochrome P450 1A2,Cytochrome P450 4,Cytochrome P450-P3,Dacarbazine,Dapagliflozin,Dasatinib,Daunorubicin,defect,deferasirox C,Delavirdine,demethylase activity,Desipramine,Desloratadine,detox,DETOXIFICATION,Dexfenfluramine,Dexmedetomidine,Diazepam,dibenzo-p-dioxin metabolic process,Dibucaine,Diclofenac,Dinoprostone,Diphenhydramine,Domperidone,dopamine,Doxepin,DRUG,drug catabolic process,drug metabolic process,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,E2,Edetic Acid,Efavirenz,electron carrier activity,electron transport pathway,Eltrombopag,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enoxacin,ENVIRONMENT,environmental,environmental factors,ENZYME,enzyme binding,Epinephrine,Epithelial Ovarian Cancer,epoxygenase P450 pathway,Ergotamine,Erlotinib,Erythromycin,Esomeprazole,Esophageal Cancer,estradiol,estrogen,estrogen dominance,estrogen related cancer,Estrone,Estropipate,Ethanol,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,fish,flavin,flavoprotein,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Fluphenazine,Flutamide,Fluvastatin,Fluvoxamine,Frovatriptan,gastric cancer,gastric cancer in Helicobacter pylori infection,Gemfibrozil,GlcNAc,Glycosylation,Grepafloxacin,Griseofulvin,Guanabenz,Haloperidol,heart,heart attack,heme,heme binding,Heme group,heme-thiolate monooxygenases,Hesperetin,heterocycle metabolic process,heterocyclic amines,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydrogen peroxide biosynthetic process,Iloperidone,Imatinib,imidazole,Imipramine,Imiquimod,Induction by,inhaled insulin,Initiator methionine,Insulin Aspart,Insulin Detemir,Insulin Glargine,Insulin Glulisine,Insulin Lispro,Insulin Regular,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketoconazole,Lansoprazole,Leflunomide,Levobupivacaine,Levofloxacin,Lidoc",
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs56276455",
        "SNP Name": "CYP1A2*3 D348N",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/14725854",
        "Video": "JX91czj1oSg",
        "Tags": "2-hydroxylation,Acenocoumarol,acetaminophen,aflatoxin B1,Agomelatine,Albendazole,Alitretinoin,alkaloid metabolic process,Almotriptan,Alosetron,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Anagrelide,Anastrozole,Antipyrine,Apixaban,Aprepitant,arachidonic acid metabolic process,aromatase activity,aromatic amine,ARTIFICIAL ESTROGEN,Asenapine,Atropine,Axitinib,Azelastine,Azithromycin,Benzyl alcohol,Betaxolol,Bortezomib,Bromazepam,Bromocriptine,Bupivacaine,Buprenorphine,Bupropion,caffeine,caffeine metabolism,caffeine oxidase activity,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,carcinogenic aromatic amine,Carmustine,Carvedilol,cellular respiration,cellular response to cadmium ion,Chlorpromazine,Chlorzoxazone,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clenbuterol,Clevidipine,Clobetasol propionate,Clomifene,Clomipramine,Clonidine,Clopidogrel,Clotrimazole,clozapine,compounds,Conjugated Estrogens,Cyclobenzaprine,CYP,CYP P450,CYP1A2,CYPIA2,CYTOCHROME,Cytochrome P(3)450,CYTOCHROME P450,Cytochrome P450 1A2,Cytochrome P450 4,Cytochrome P450-P3,Dacarbazine,Dapagliflozin,Dasatinib,Daunorubicin,Delavirdine,demethylase activity,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexfenfluramine,Dexmedetomidine,Diazepam,dibenzo-p-dioxin metabolic process,Diclofenac,Dinoprostone,Diphenhydramine,Domperidone,Dopamine,Doxepin,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Edetic Acid,Efavirenz,electron carrier activity,electron transport pathway,Eltrombopag,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enoxacin,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,ENZYME,enzyme binding,Epinephrine,epoxygenase P450 pathway,Ergotamine,Erlotinib,Erythromycin,Estradiol,ESTROGEN,Estrone,Estropipate,Ethanol,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Fluphenazine,Flutamide,Fluvastatin,Fluvoxamine,Frovatriptan,Gemfibrozil,Griseofulvin,Guanabenz,Haloperidol,HEME,heme binding,heme-thiolate monooxygenases,Hesperetin,heterocycle metabolic process,heterocyclic amines,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydrogen peroxide biosynthetic process,Iloperidone,Imatinib,imidazole,Imipramine,Imiquimod,inhaled insulin,Insulin Aspart,Insulin Detemir,Insulin Glargine,Insulin Glulisine,Insulin Lispro,Insulin Regular,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketoconazole,Lansoprazole,Leflunomide,Levobupivacaine,Levofloxacin,Lidocaine,LIVER,LIVER ENZYME,Lomefloxacin,Lopinavir,Lorcaserin,Losartan,Lumiracoxib,lung development,Malathion,Maprotiline,Meclizine,Melatonin,Membrane,Menadione,Metal-binding,Methadone,Methimazole,Methotrimeprazine,Methoxsalen,Methoxyflurane,methylation,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,molecular oxygen,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-hydroxylation,N3-demethylation,Nabumetone,NADPH,NADPH-dependent,Nafcillin,Naproxen,Nelfinavir,Nevirapine,Niclosamide,Nicotine,Nifedipine,Nilvadipine,Nisoldipine,Nitric Oxide,Nitroprusside,Norepinephrine,Norfloxacin,Nortriptyline,O-deethylation,Ofloxacin,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Oxaliplatin,oxidation,oxidation-reduction process,oxidative deethylation,oxidative demethylation,oxidizes,Oxidoreductase,oxidoreductase activity,Oxtriphylline,oxygen,P450,Palonosetron,Pantoprazole,Pazopanib,Pefloxacin,Pentamidine,Pentoxifylline,Peripheral membrane protein,Perphenazine,phenacetin,Phenobarbital,Phentermine,Phenylephrine,Phenylpropanolamine,Pimozide,Pipotiaz",
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs2470890",
        "SNP Name": "CYP1A2 1545T>C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2470890",
        "Video": "JX91czj1oSg",
        "Tags": "2-hydroxylation,Acenocoumarol,acetaminophen,aflatoxin B1,Agomelatine,Albendazole,Alitretinoin,alkaloid metabolic process,Almotriptan,Alosetron,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Anagrelide,Anastrozole,antidepressant,antidepressant side effect,Antipyrine,Apixaban,Aprepitant,arachidonic acid metabolic process,aromatase activity,aromatic amine,ARTIFICIAL ESTROGEN,Asenapine,Atropine,Axitinib,Azelastine,Azithromycin,Benzyl alcohol,Betaxolol,Bortezomib,Bromazepam,Bromocriptine,Bupivacaine,Buprenorphine,Bupropion,caffeien and Parkinson's disease,caffeine,caffeine metabolism,caffeine oxidase activity,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,carcinogenic aromatic amine,Carmustine,Carvedilol,cellular respiration,cellular response to cadmium ion,Chlorpromazine,Chlorzoxazone,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clenbuterol,Clevidipine,Clobetasol propionate,Clomifene,Clomipramine,Clonidine,Clopidogrel,Clotrimazole,clozapine,clozapine metabolism,clozapine response,compounds,Conjugated Estrogens,Cyclobenzaprine,CYP,CYP P450,CYP1A2,CYPIA2,CYTOCHROME,Cytochrome P(3)450,CYTOCHROME P450,Cytochrome P450 1A2,Cytochrome P450 4,Cytochrome P450-P3,Dacarbazine,Dapagliflozin,Dasatinib,Daunorubicin,deferasirox,Delavirdine,demethylase activity,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexfenfluramine,Dexmedetomidine,Diazepam,dibenzo-p-dioxin metabolic process,Diclofenac,Dinoprostone,Diphenhydramine,Domperidone,Dopamine,Doxepin,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Edetic Acid,Efavirenz,electron carrier activity,electron transport pathway,Eltrombopag,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enoxacin,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,ENZYME,enzyme binding,Epinephrine,epoxygenase P450 pathway,Ergotamine,Erlotinib,Erythromycin,Estradiol,ESTROGEN,Estrone,Estropipate,Ethanol,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Fluphenazine,Flutamide,Fluvastatin,Fluvoxamine,Frovatriptan,Gemfibrozil,Griseofulvin,Guanabenz,Haloperidol,HEME,heme binding,heme-thiolate monooxygenases,Hesperetin,heterocycle metabolic process,heterocyclic amines,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydrogen peroxide biosynthetic process,Iloperidone,Imatinib,imidazole,Imipramine,Imiquimod,inhaled insulin,Insulin Aspart,Insulin Detemir,Insulin Glargine,Insulin Glulisine,Insulin Lispro,Insulin Regular,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketoconazole,Lansoprazole,Leflunomide,Levobupivacaine,Levofloxacin,Lidocaine,LIVER,LIVER ENZYME,Lomefloxacin,Lopinavir,Lorcaserin,Losartan,Lumiracoxib,lung cancer,lung development,Malathion,Maprotiline,Meclizine,Melatonin,Membrane,Menadione,Metal-binding,Methadone,Methimazole,Methotrimeprazine,Methoxsalen,Methoxyflurane,methylation,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,molecular oxygen,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-hydroxylation,N3-demethylation,Nabumetone,NADPH,NADPH-dependent,Nafcillin,Naproxen,Nelfinavir,Nevirapine,Niclosamide,Nicotine,Nifedipine,Nilvadipine,Nisoldipine,Nitric Oxide,Nitroprusside,Norepinephrine,Norfloxacin,Nortriptyline,O-deethylation,Ofloxacin,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Oxaliplatin,oxidation,oxidation-reduction process,oxidative deethylation,oxidative demethylation,oxidizes,Oxidoreductase,oxidoreductase activity,Oxtriphylline,oxygen,P450,Palonosetron,Pantoprazole,Parkinson,Parkinson's disease,paroxetine",
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs3825932",
        "SNP Name": "CTSH A6975G",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Benzethonium Chloride"
    },
    {
        "SNP ID": "rs1800067",
        "SNP Name": "ERCC4 R415Q",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "A-Tocopheryl Hydrogen Succinate"
    },
    {
        "SNP ID": "rs1799801",
        "SNP Name": "ERCC4 S835S",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "A-Tocopheryl Hydrogen Succinate"
    },
    {
        "SNP ID": "rs35979293",
        "SNP Name": "CD19 Pro235Pro",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "FD&C Yellow #6 Aluminum Lake Dye"
    },
    {
        "SNP ID": "rs28934592",
        "SNP Name": "HSD11B2 R208H",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs28934591",
        "SNP Name": "HSD11B2 R213C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs4790353",
        "SNP Name": "PAFAH1B1 G2578648T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs224534",
        "SNP Name": "TRPV1 T469I",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs11868035",
        "SNP Name": "SREBF1 C*835T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs9902941",
        "SNP Name": "SREBF1/SREBP G11566A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs9902941",
        "SNP Name": "SREBF1/SREBP G11566A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs1889018",
        "SNP Name": "SREBF1/SREBP C10586T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs1889018",
        "SNP Name": "SREBF1/SREBP C10586T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs1042173",
        "SNP Name": "SLC6A4 A28525011C",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amphotericin B"
    },
    {
        "SNP ID": "rs2066713",
        "SNP Name": "SLC6A4 G28551665A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amphotericin B"
    },
    {
        "SNP ID": "rs2289681",
        "SNP Name": "GFAP A286A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs2071409",
        "SNP Name": "MPO A15067C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2071409",
        "Video": null,
        "Tags": "84 kDa myeloperoxidase,89 kDa myeloperoxidase,acute kidney injury,aging,Alternative splicing,Alzheimer,Alzheimer's disease,Ambient Air Pollution and Respiratory-related School Absences,azurophil granule,Binds 1 calcium ion per monomer,Binds 1 heme B (iron-protoporphyrin IX) group covalently per monomer,blood cells,calcium,candida,cardiac surgery,chromatin binding,Cl- + H2O2 + H+ = HClO + H2O,Cl- + H2O2 = HOCl + 2 H2O,defense response,defense response to fungus,development of benzene hematotoxicity,Disease mutation,disorder characterized by decreased myeloperoxidase activity in neutrophils and monocytes that results in disseminated candidiasis,Disulfide bond,disulfide-linked,Each monomer consists of a light and a heavy chain,extracellular space,extracellular vesicular exosome,ferritin,fungal,Glycoprotein,heart,heme,heme binding,heparin binding,Homodimer,Hydrogen peroxide,hydrogen peroxide catabolic process,hypochlorous acid biosynthetic process,hypohalous acid,immune system,immunity,iron,kidney,kidney disease,low-density lipoprotein particle remodeling,Lysosome,metal ion binding,Metal-binding,mitochondrion,mortality,MPO,MPO catalyzes the production of hypohalous acids,mpod,Myeloperoxidase,Myeloperoxidase deficiency,Myeloperoxidase heavy chain,Myeloperoxidase light chain,Nasopharyngeal Carcinoma,negative regulation of apoptotic process,negative regulation of growth of symbiont in host,nucleus,Oxidation,oxidation-reduction process,Oxidoreductase,Peroxidase,peroxidase activity,peroxidase family,PMN,PMN microbicidal activity,Polymorphism,Polymorphisms,polymorphonuclear leukocytes,psychiatric,psychology,red blood cell,relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma,removal of superoxide radicals,respiratory burst involved in defense response,response to food,response to lipopolysaccharide,response to mechanical stimulus,response to oxidative stress,response to yeast,secretory granule,sepsis,Signal,susceptibility to benzene-induced hematotoxicity,toxin,white blood cell,XPO subfamily",
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs28730837",
        "SNP Name": "MPO C7900T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs28730837",
        "Video": null,
        "Tags": "84 kDa myeloperoxidase,89 kDa myeloperoxidase,aging,Alternative splicing,Alzheimer,Alzheimer's disease,artery,Atherosclerosis,azurophil granule,Binds 1 calcium ion per monomer,Binds 1 heme B (iron-protoporphyrin IX) group covalently per monomer,blood cells,blood pressure,calcium,candida,chromatin binding,Cl- + H2O2 + H+ = HClO + H2O,Cl- + H2O2 = HOCl + 2 H2O,defense response,defense response to fungus,Disease mutation,disorder characterized by decreased myeloperoxidase activity in neutrophils and monocytes that results in disseminated candidiasis,Disulfide bond,disulfide-linked,Each monomer consists of a light and a heavy chain,extracellular space,extracellular vesicular exosome,ferritin,fungal,Genetic and Environmental Factors to Systemic Inflammatory Biomarker Concentrations,Glycoprotein,heme,heme binding,heparin binding,high BP,Homodimer,Hydrogen peroxide,hydrogen peroxide catabolic process,hypertension,hypochlorous acid biosynthetic process,hypohalous acid,iron,low-density lipoprotein particle remodeling,Lysosome,metal ion binding,Metal-binding,mitochondrion,MPO,MPO catalyzes the production of hypohalous acids,mpod,Myeloperoxidase,Myeloperoxidase deficiency,Myeloperoxidase heavy chain,Myeloperoxidase light chain,negative regulation of apoptotic process,negative regulation of growth of symbiont in host,nucleus,Oxidation,oxidation-reduction process,Oxidoreductase,Peroxidase,peroxidase activity,peroxidase family,PMN,PMN microbicidal activity,Polymorphism,polymorphonuclear leukocytes,psychiatric,psychology,red blood cell,removal of superoxide radicals,respiratory burst involved in defense response,response to food,response to lipopolysaccharide,response to mechanical stimulus,response to oxidative stress,response to yeast,secretory granule,Signal,toxin,white blood cell,XPO subfamily",
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs34377097",
        "SNP Name": "TBXA2R R60L",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phenol Red"
    },
    {
        "SNP ID": "rs2230199",
        "SNP Name": "C3 R102G",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Human Serum Albumin"
    },
    {
        "SNP ID": "rs2230199",
        "SNP Name": "C3 R102G",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Ovalbumin"
    },
    {
        "SNP ID": "rs5491",
        "SNP Name": "ICAM1 L56M",
        "Risk Allele": "T",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs5498",
        "SNP Name": "ICAM1 L469G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs8192709",
        "SNP Name": "CYP2B6 R22C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs8192709",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs35303484",
        "SNP Name": "CYP2B6 A136G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs35303484",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,antiretroviral therapy,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,S-methadone plasma levels,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs3745274",
        "SNP Name": "CYP2B6 Q172H",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs3745274",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,anti-tuberculosis drug-induced hepatotoxicity,antibiotics,Antipyrine,antiretroviral therapy,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,breast cancer,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,chemotherapy,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,efavirenz plasma concentration,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,methadone S-enantiomer,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,nevirapine toxicity,Nicardipine,Nicotine,nicotine metabolism,Nifedipine,Nilotinib,Nitric Oxide,opioid addiction,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Pharmacogenetics,pharmacokinetics,Phenobarbital,Phenytoin,plasma efavirenz exposure,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,smoking,smoking cessation,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs36079186",
        "SNP Name": "CYP2B6 T20715C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940150/",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs2279345",
        "SNP Name": "CYP2B6 T23499C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2279345",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,methadone plasma concentrationefavirenz concentrations,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs28399499",
        "SNP Name": "CYP2B6 I328T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs28399499",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,efavirenz exposure,efavirenz response,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,nevirapine response,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,plasma efavirenz concentrations,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs34097093",
        "SNP Name": "CYP2B6 C1132T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940150/",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs8192719",
        "SNP Name": "CYP2B6 C26570T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs8192719",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,plasma efavirenz concentrations,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,S-methadone plasma levels,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs7260329",
        "SNP Name": "CYP2B6 G29435A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.nature.com/npp/journal/v37/n3/full/npp2011232a.html",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs1042389",
        "SNP Name": "CYP2B6 T1421C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1042389",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,Hirschsprung Disease urinary phytoestrogens,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,idiopathic male infertility,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,male infertility,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs25487",
        "SNP Name": "XRCC1 G399A",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs25489",
        "SNP Name": "XRCC1 A280H",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs1799782",
        "SNP Name": "XRCC1 A194T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs50871",
        "SNP Name": "ERCC2/XPD G16331T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs3212986",
        "SNP Name": "ERCC1 G540K",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "A-Tocopheryl Hydrogen Succinate"
    },
    {
        "SNP ID": "rs11615",
        "SNP Name": "ERCC1 N118N",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "A-Tocopheryl Hydrogen Succinate"
    },
    {
        "SNP ID": "rs1405655",
        "SNP Name": "NR1H2 T50882619C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs6084312",
        "SNP Name": "SLC4A11 T463T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Borate"
    },
    {
        "SNP ID": "rs3827075",
        "SNP Name": "SLC4A11 R161R",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Borate"
    },
    {
        "SNP ID": "rs3178250",
        "SNP Name": "BMP2 T*465C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": "8ez_0J3AQDs",
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs235756",
        "SNP Name": "BMP2 C282Y",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs235756",
        "Video": "8ez_0J3AQDs",
        "Tags": "activation of MAPK activity,advanced non-small cell lung cancer,atrioventricular valve morphogenesis,BMP receptor binding,BMP signaling pathway,BMP signaling pathway involved in heart induction,BMP-2,BMP-2A,BMP2,BMP2A,bone,bone mineralization,bone mineralization involved in bone maturation,Bone morphogenetic protein 2,Bone morphogenetic protein 2A,bone production,Brain Metastasis,branching involved in ureteric bud morphogenesis,cardiac cell differentiation,cardiac epithelial to mesenchymal transition,cardiac muscle cell differentiation,cardiac muscle tissue morphogenesis,cardiocyte differentiation,cell fate commitment,cell surface,cell-cell signaling,cellular response to BMP stimulus,cellular response to organic cyclic compound,chondrocyte differentiation,Chondrogenesis,Cleavage on pair of basic residues,Cleaved by PCSK5,corticotropin hormone secreting cell differentiation,Cytokine,dentistry,development of bone and cartilage,Developmental protein,Differentiation,Disulfide bond,DNA-templated,embryo development,embryonic heart tube anterior/posterior pattern specification,endocardial cushion morphogenesis,epithelial to mesenchymal transition,extracellular matrix organization,extracellular region,extracellular space,Glycoprotein,growth,Growth factor,Haemochromatosis,heart development,hedgehog pathway,Hemochromatosis,high mannose,Homodimer,hormone,Implantation of BMP-2 in a collagen sponge induces new bone formation,in utero embryonic development,inflammatory response,inner ear development,Interacts with ASPN,Interacts with GREM2,Interacts with SOSTDC1,lung cancer,mesenchymal cell differentiation,mesenchymal cell proliferation involved in ureteric bud development,mesenchyme development,negative regulation of aldosterone biosynthetic process,negative regulation of calcium-independent cell-cell adhesion,negative regulation of canonical Wnt signaling pathway,negative regulation of cardiac muscle cell differentiation,negative regulation of cell cycle,negative regulation of cell proliferation,negative regulation of cortisol biosynthetic process,negative regulation of insulin-like growth factor receptor signaling pathway,negative regulation of steroid biosynthetic process,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,negative regulation of Wnt signaling pathway involved in heart development,Notch signaling pathway,odontogenesis of dentin-containing tooth,organ morphogenesis,osteoblast differentiation,Osteogenesis,oxidation-reduction process,Pancreatic Cancer,pathway-restricted SMAD protein phosphorylation,pericardium development,phosphatase activator activity,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of bone mineralization,positive regulation of cartilage development,positive regulation of cell migration,positive regulation of endothelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of ERK1 and ERK2 cascade,positive regulation of fat cell differentiation,positive regulation of gene expression,positive regulation of MAPK cascade,positive regulation of neuron differentiation,positive regulation of odontogenesis,positive regulation of ossification,positive regulation of osteoblast differentiation,positive regulation of osteoblast proliferation,positive regulation of p38MAPK cascade,positive regulation of pathway-restricted SMAD protein phosphorylation,positive regulation of phosphatase activity,positive regulation of protein phosphorylation,positive regulation of transcription,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,positive regulation of Wnt signaling pathway,positive regulation of Wnt signaling pathway by BMP signaling pathway,protein binding,protein destabilization,protein heterodimerization",
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs17576",
        "SNP Name": "THBS2 Q279R",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Calcium Chloride"
    },
    {
        "SNP ID": "rs17576",
        "SNP Name": "THBS2 Q279R",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Taurodeoxycholate"
    },
    {
        "SNP ID": "rs1883832",
        "SNP Name": "CD40 T44746982C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs28931586",
        "SNP Name": "CD40 C83A",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs1051295",
        "SNP Name": "KCNB1 T*615C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs756529",
        "SNP Name": "KCNB1 G18207100A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs380417",
        "SNP Name": "APP .T27272159C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "A-Tocopheryl Hydrogen Succinate"
    },
    {
        "SNP ID": "rs1064422",
        "SNP Name": "IGLL1/14.1 P142L",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Acetone"
    },
    {
        "SNP ID": "rs140174",
        "SNP Name": "IGLL1/14.1 T4513C",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Acetone"
    },
    {
        "SNP ID": "rs2071747",
        "SNP Name": "HMOX1 A7H",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Acetone"
    },
    {
        "SNP ID": "rs2899292",
        "SNP Name": "LGALS1/GAL1 C54T",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs1800278",
        "SNP Name": "DMD N2912D",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Disodium Phosphate"
    },
    {
        "SNP ID": "rs1800278",
        "SNP Name": "DMD N2912D",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs921896",
        "SNP Name": "DMD T32213962C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Disodium Phosphate"
    },
    {
        "SNP ID": "rs921896",
        "SNP Name": "DMD T32213962C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Sulfate"
    }
]